Inhaled pyrazinamide proliposome for targeting alveolar macrophages

Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies

(2011) Wipaporn Rojanarat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Controlled release application of multilamellar vesicles: a novel drug delivery approach

(2010) Sunil A. Agnihotri et al.   DRUG DELIVERY

Development and characterisation of freeze-dried liposomes containing two anti-asthma drugs

(2010) A.M.A. Elhissi et al.   Micro & Nano Letters

The near future: Improving the activity of rifamycins and pyrazinamide

(2010) D.A. Mitchison et al.   TUBERCULOSIS

A New Insight into Pyrazinamide Polymorphic Forms and their Thermodynamic Relationships

(2009) Ricardo A. E. Castro et al.   CRYSTAL GROWTH & DESIGN

Excipient-free nanoporous microparticles of budesonide for pulmonary delivery

(2009) Lorraine M. Nolan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Monitoring safety of liposomes containing rifampicin on respiratory cell lines andin vitroefficacy againstMycobacterium bovisin alveolar macrophages

(2009) Narumon Changsan et al.   JOURNAL OF DRUG TARGETING

Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation

(2008) Narumon Changsan et al.   JOURNAL OF PHARMACEUTICAL SCIENCES